Scott Atlas
Scott W. Atlas, MD is the Robert Wesson Senior Fellow in health policy at the Hoover Institution of Stanford University. He investigates the impact of government and the private sector on access, quality, and pricing in health care, trends in health care innovation, and key economic and civil liberties issues related to health policies.
He is a frequent policy advisor to policymakers in the United States and other countries. He has served as senior advisor for health policy to several candidates for President, members of the US Congress, and health agencies. From August through November, 2020, he served as Special Advisor to the President and a member of the White House Coronavirus Task Force.
Affiliations
RECENT AWARDS (2022)
The Encounter Prize
“Standing up to injustice and facing down the madding crowd of conformity requires enormous patience, equilibrium, insight, and courage-the most important virtue, Aristotle observed, because without it none of the other virtues can flourish. The Encounter Prize for Advancing American Ideals pays tribute to those who embody this rare combination of virtues in their lives and work.”
RECENT AWARDS (2021)
Hillsdale Freedom Leadership Award
Dr. Atlas was honored “in recognition of his dedication to individual freedom and the free society.” In presenting the award, Hillsdale President Larry P. Arnn praised Atlas for his courage and wisdom in “speaking the truth in the face of consequences” while counseling President Trump about the pandemic. He added that “every one of us has discovered a brave and brilliant man.”
RECENT AWARDS (2021)
CPI Freedom Fighter of the Year Award
Dr. Atlas was the recipient of the first-annual Conservative Partnership Institute’s highest honor, bestowed upon an individual for their courage and dedication to truth and liberty. “Dr. Atlas’ voice was a beacon of truth for the American people throughout the height of the Coronavirus pandemic and continues to be to this day. He scrutinized the restrictions and unprecedented mandates and advocated for policymakers to objectively consider both the virus’ harms and the totality of impact of policies.”
